BriaCell Therapeutics Corp. 10-K filing
Filed 2025-10-16 · Report date 2025-07-31 · 2025 FY
Filing metadata
- Accession number
- 0001493152-25-018212
- Form type
- 10-K
- CIK
- 0001610820
- Primary document
- https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BriaCell Therapeutics Corp..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-27.2M | - | - |
| Net Income | $-26.3M | - | - |
| Eps Basic | -62.19 | - | - |
| Eps Diluted | -62.19 | - | - |
| Cash And Equivalents | $10.5M | - | - |
| Total Assets | $21.6M | - | - |
| Operating Cash Flow | $-28.2M | - | - |
| Capital Expenditures | $456,801 | - | - |